Pulmonary Arterial Hypertension (PH) is characterized by excessive pulmonary vascular remodelling, resulting in elevated pulmonary artery and right heart pressures. Eventually, the right ventricle cannot adapt to the increase in afterload, and PH-patients die as a consequence of overt right heart failure. The main symptoms of the patients are reduced exercise tolerance, shortness of breath and other symptoms related to right heart failure such as oedema. This thesis aimed to obtain more knowledge of the pathophysiology of these symptoms and investigate the e ects of two di erent therapeutic strategies.
In Chapter 2 we investigated if exercise training could be bene cial to improve exercise capacity in PH. As exercise training is still contra-indicated because of fear that the right ventricle of PH-patients could not cope with a further increase in right ventricular (RV) afterload during exercise, we assessed the e ects of exercise training in an animal model (monocrotaline (MCT) rat model) for PH. We hypothesized that the e ect of exercise training was dependent on the adaptation of the right ventricle to increased afterload and we therefore induced two types of PH, a stable PH with preserved cardiac function (low dose (40 mg/kg) of MCT) and a progressive PH with right heart failure (high dose (60 mg/kg) of MCT). After two weeks of MCT, all rats had developed PH (assessed by echocardiography) and the exercise training was initiated. After 4 weeks of exercise training, we observed opposite e ects of exercise training in stable and progressive PH. In stable PH, exercise training was bene cial as it improved exercise capacity and RV capillarization. However, in progressive PH, exercise training was detrimental: exercise training accelerated the progression towards right heart failure and was associated with manifest RV in ammation.
Encouraged by the ndings that exercise training was bene cial in stable PH rats, we performed a clinical study in Chapter 3 to assess the e ects of exercise training in patients with idiopathic PH who were clinically stable and had no change in therapy for at least three months prior to inclusion. Eventually, nineteen patients were enrolled in this study, who underwent an exercise training program (three times a week, for a period of 12 weeks) in a rehabilitation center located within ve kilometres from their homes. Before and after 12 weeks of training, maximal and submaximal exercise capacity and quadriceps muscle function were assessed at the VU University Medical Center. Moreover, in a subset of 12 patients we were able to obtain quadriceps muscle biopsies before and after training to analyse the e ects of exercise training on skeletal muscle morphology in more detail. Our study revealed that exercise training could improve submaximal exercise capacity and quadriceps muscle function (both strength and endurance) in patients with stable PH. Interestingly, the enhanced quadriceps muscle function after exercise training was associated with improvements in oxygen handling of the quadriceps muscle bers.
Chapter 8
In Chapter 4 we investigated whether alterations in myo lament phosphorylation and function could underlie the opposite e ects of exercise training discussed in Chapter 2. We hypothesized that exercise training in progressive PH induced an overload of catecholamines (suggested by the observed RV in ammation), thereby altering beta-adrenergic receptor signalling and a ecting myo lament phosphorylation and function. Histological analyses revealed that in addition to the previous reported increase in lymphocytes, exercise training in progressive PH also induced in ltration of macrophages and granulocytes speci cally in the right ventricle. Moreover, opposite e ects of exercise training were again observed in myo lament phosphorylation where exercise training increased phosphorylation in stable PH and decreased phosphorylation in progressive PH of the myo lament proteins troponin I, troponin T and myosin binding protein C. Furthermore, reduced myo lament phosphorylation in progressive PH was associated with increased protein phosphatase 1 expression. Interestingly, we were able to analyse the functional consequences of the altered myo lament phosphorylation by isolation of single cardiomyocytes. These functional measurements revealed that exercise training was able to improve active force in both stable and progressive PH. However, in progressive PH this increase in active force was at the expanse of passive force indicating severe diastolic dysfunction. The role of diastolic dysfunction in progressive PH rats and patients will be investigated further.
As we observed signs of catecholamine overload in progressive PH rats who developed overt right heart failure, we subsequently investigated the e ects of beta-blocker therapy in Chapter 5. Beta-blockers are often used as therapeutic strategy for the treatment of patients with left heart failure and are able to restore the detrimental e ects of catecholamines. However, beta-blockers are contra-indicated for the treatment for PH as it is feared that patients can not cope with the transient myocardial depressant e ects of beta-blockers. On the other hand, this fear is substantiated on studies using high dose of a-selective ( rst generation) beta-blockers, who only assessed acute e ects of beta-blockers. We therefore hypothesized that chronic use of a low-dosed cardio-selective beta-blocker (bisoprolol 10 mg) could have bene cial e ects on survival and RV function in rats with progressive PH. Rats were randomized in bisoprolol or vehicle 10 days after MCT-injection. Echocardiography and pressure volume relations were used to asses the e ects of bisoprolol on arterial-ventricular coupling and diastolic function. Bisoprolol delayed the progression of right heart failure and improved survival. Bisoprolol had no e ect on RV afterload, however it improved RV contractility signicantly, resulting in a partially restored arterial-ventricular coupling. Moreover, diastolic function was signi cantly improved after bisoprolol treatment. Interestingly, the improvements in RV function were associated with decreased RV brosis and RV in ammation. The clinical applicability of bisoprolol for the treatment of patients with PH will be further evaluated in a clinical phase I/II setting.
Summary 119 Respiratory muscle dysfunction is suggested to be associated with increased sensation of dyspnoea in patients with PH. Especially, inspiratory muscle function seems impaired in PHpatients. As patients with PH hyperventilate continuously, we hypothesized in Chapter 6 that over-activity of the diaphragm muscle (main muscle of inspiration) could induce alterations in contractile properties and morphology resulting in reduced inspiratory muscle function.
As obtaining diaphragm muscle biopsies of patients with PH is hampered by ethical di culties, we investigated diaphragm muscle function and morphology of rats with progressive PH. Telemetry revealed that breathing frequencies of PH rats were signi cantly elevated. Furthermore, force generating capacity of diaphragm muscle strips was signi cantly reduced, indicated by lower twitch and tetanic force and shifted force-frequency curve in PH rats.
Subsequent histological analyses revealed manifest atrophy of the diaphragm muscle bers, which can even further a ect force generating capacity of the diaphragm muscle. Interestingly, we were able to extrapolate our pre-clinical ndings to patients who died of PH, as manifest atrophy was also present in diaphragm muscle bers of PH patients compared to controls. Importantly, these alterations in diaphragm muscle function were speci c to the diaphragm as skeletal muscle function was unaltered in PH-rats. Future research will investigate the causal relation between over-activity and diaphragm muscle function in PH by use of pharmaceutical interventions.
